(Q79291069)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa (English)

1 reference

1 April 2024

main subject

Pseudomonas aeruginosa

1 reference

Shimon Kusne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Kim Coley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Paulo Fontes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

David Paterson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Peter K. Linden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14614688

1 April 2024

David J. Kramer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14614688

1 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14614688

1 April 2024

publication date

29 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 December 2019

http://academic.oup.com/cid/article-pdf/37/11/e154/1063308/37-11-e154.pdf

file format

Portable Document Format

1 reference

Clinical Infectious Diseases

1 April 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

e154-60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System

21 December 2019

cites work

1

1 reference

Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study

1 April 2024

2

1 reference

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

1 April 2024

3

1 reference

Ventilator-associated pneumonia due to Pseudomonas aeruginosa

1 April 2024

4

1 reference

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 April 2024

5

1 reference

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

1 April 2024

6

1 reference

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

1 April 2024

7

1 reference

Resistance patterns among nosocomial pathogens: trends over the past few years

1 April 2024

8

1 reference

Streptomyces pneumonia in a patient with human immunodeficiency virus infection: case report and review of the literature on invasive streptomyces infections

1 April 2024

9

1 reference

Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms

1 April 2024

10

1 reference

Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa

1 April 2024

11

1 reference

Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon

1 April 2024

12

1 reference

Aminoglycosides: activity and resistance

1 April 2024

13

1 reference

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

1 April 2024

14

1 reference

Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned

1 April 2024

15

1 reference

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 April 2024

16

1 reference

Colistin: an antimicrobial for the 21st century?

1 April 2024

17

1 reference

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

1 April 2024

18

1 reference

Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995

1 April 2024

19

1 reference

Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents

1 April 2024

20

1 reference

1 April 2024

The aminoglycosides

21

1 reference

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration

1 April 2024

22

1 reference

Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia

1 April 2024

23

1 reference

The American Review of Respiratory Disease

1 April 2024

24

129

168

Schoenberger

1984

1 reference

Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model

1 April 2024

25

1 reference

Endocarditis due to Pseudomonas aeruginosa in a heroin addict. Successful treatment with trimethoprim-Sulfamethoxazole mixture plus colistin

1 April 2024

26

1 reference

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

1 April 2024

28

1 reference

Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.

1 April 2024

29

1 reference

Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa

1 April 2024

31

1 reference

Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance

1 April 2024

32

1 reference

Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa: effect of magnesium depletion.

1 April 2024

33

1 reference

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients

1 April 2024

34

1 reference

Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study

1 April 2024

35

1 reference

RecurrentPseudomonas aeruginosaPneumonia in Ventilated Patients

1 April 2024

36

1 reference

In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics

1 April 2024

37

1 reference

Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes.

1 April 2024

38

1 reference

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

1 April 2024

39

1 reference

Neurotoxic and nephrotoxic effects of colistin in patients with renal disease

1 April 2024

40

1 reference

1 April 2024

Identifiers

DOI

10.1086/379611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14614688%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference